Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Failure of conventional treatment and losartan in Camurati-Engelmann disease: A case report.

Combier A, Palazzo E, Forien M, Gardette A, Dieudé P, Ottaviani S.

Joint Bone Spine. 2018 Oct;85(5):649-650. doi: 10.1016/j.jbspin.2018.01.015. Epub 2018 Feb 13. No abstract available.

PMID:
29452301
2.

Tophus size is associated with hallux valgus deformity in gout.

Blandin C, Forien M, Gardette A, Palazzo E, Dieudé P, Ottaviani S.

Eur J Clin Invest. 2018 Jan;48(1). doi: 10.1111/eci.12862. Epub 2017 Dec 7.

PMID:
29171878
3.

Comparison of ultrasonography and radiography of the wrist for diagnosis of calcium pyrophosphate deposition.

Forien M, Combier A, Gardette A, Palazzo E, Dieudé P, Ottaviani S.

Joint Bone Spine. 2018 Oct;85(5):615-618. doi: 10.1016/j.jbspin.2017.09.006. Epub 2017 Sep 28.

PMID:
28965942
4.

Subacute thyroiditis in psoriatic arthritis treated by adalimumab.

Senlis M, Ottaviani S, Gardette A, Palazzo E, Coustet B, Dieudé P.

Joint Bone Spine. 2017 Dec;84(6):745-746. doi: 10.1016/j.jbspin.2016.09.015. Epub 2016 Nov 4. No abstract available.

PMID:
27825573
5.

Body mass index and response to abatacept in rheumatoid arthritis.

Gardette A, Ottaviani S, Sellam J, Berenbaum F, Lioté F, Fautrel B, Palazzo E, Meyer A, Sibilia J, Dieudé P.

Eur J Clin Invest. 2016 Dec;46(12):1048-1052. doi: 10.1111/eci.12691. Epub 2016 Nov 7.

PMID:
27736006
6.

Varicella-Zoster virus hip arthritis in a rheumatoid arthritis patient.

Senlis M, Ottaviani S, Gardette A, Palazzo E, Coustet B, Dieudé P.

Joint Bone Spine. 2017 Mar;84(2):241-242. doi: 10.1016/j.jbspin.2016.02.030. Epub 2016 Jun 3. No abstract available.

PMID:
27269653
7.

Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.

Gardette A, Ottaviani S, Sellam J, Berenbaum F, Lioté F, Meyer A, Sibilia J, Fautrel B, Palazzo E, Dieudé P.

Clin Rheumatol. 2016 Apr;35(4):857-61. doi: 10.1007/s10067-016-3183-3. Epub 2016 Jan 22.

PMID:
26801332
8.

Body Mass Index and response to rituximab in rheumatoid arthritis.

Ottaviani S, Gardette A, Roy C, Tubach F, Gill G, Palazzo E, Meyer O, Dieudé P.

Joint Bone Spine. 2015 Dec;82(6):432-6. doi: 10.1016/j.jbspin.2015.02.011. Epub 2015 Jul 14.

PMID:
26184536
9.

Body mass index and response to infliximab in rheumatoid arthritis.

Ottaviani S, Gardette A, Tubach F, Roy C, Palazzo E, Gill G, Meyer O, Dieudé P.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):478-83. Epub 2015 May 11.

PMID:
25962513
10.

High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis.

Gardette A, Ottaviani S, Tubach F, Roy C, Nicaise-Roland P, Palazzo E, Gill G, Meyer O, Dieudé P.

Joint Bone Spine. 2014 Oct;81(5):416-20. doi: 10.1016/j.jbspin.2014.06.001. Epub 2014 Jul 3.

PMID:
24998790
11.

Body mass index influences the response to infliximab in ankylosing spondylitis.

Ottaviani S, Allanore Y, Tubach F, Forien M, Gardette A, Pasquet B, Palazzo E, Meunier M, Hayem G, Job-Deslandre C, Kahan A, Meyer O, Dieudé P.

Arthritis Res Ther. 2012 May 14;14(3):R115. doi: 10.1186/ar3841.

Supplemental Content

Loading ...
Support Center